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SUMMARY
Background—Transgender women (TGW) are among the groups at highest risk for HIV 
infection, with a prevalence of 27.7% in the United States, but despite this high risk, TGW have 
documented high rates of undiagnosed HIV infection. We propose that this disparity can be 
addressed by characterizing TGW in a molecular transmission network to prioritize public health 
activities.
Methods—Since 2006, HIV pol sequences from drug resistance testing have been reported to 
Los Angeles County (LAC) Department of Public Health and linked to demographic data, gender, 
and HIV transmission risk factor data for each case in the enhanced HIV/AIDS Reporting System 
(eHARS). We reconstructed a molecular transmission network using HIV-TRACE (pairwise 
genetic distance threshold of 0.015 substitutions/site) from the earliest pol sequences from 22,398 
unique individuals, including 412 (2%) self-identified TGW. We examined the possible predictors 
of clustering using multivariate logistic regression. We characterized the genetically-linked 
partners of TGW and calculated assortativity—the tendency for persons to link to other persons 
with the same attributes—for each transmission risk group.
Findings—We found that 36% of individuals (8,133/22,398) clustered in the network across 
1,722 molecular transmission clusters. TGW who indicated a sexual risk factor clustered at the 
highest frequency in the network: 147/345 (42.6%) linked to at least one other person (p<0.001). 
TGW were assortative in the network (0.06; p<0.001), indicating that they tended to link to other 
TGW. TGW were more likely than expected to link to other TGW and cisgender men who did not 
identify as men who have sex with men (MSM). TGW were less likely than expected to link to 
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MSM, despite the high prevalence of HIV among MSM. TGW were distributed across 126 
clusters, and cis-individuals linked to one TGW were 9.2 times more likely to link to a second 
TGW than other individuals in the surveillance database. Reconstruction of the transmission 
network is limited by sample availability, but sequences were available for >40% of diagnoses.
Interpretation—TGW in LAC were more likely to cluster than any other risk group, suggesting 
high transmission rates—despite the small number of TGW in the network. TGW tended to cluster 
with other TGW, indicating shared risk activities (i.e., linked directly or through shared partners). 
This assortativity, and the observed tendency for linkage with cisgender men who did not identify 
as MSM, demonstrates the potential to use molecular epidemiology to both identify clusters likely 
to include undiagnosed HIV-infected TGW and improve the targeting of public health prevention 
and treatment services to TGW.
INTRODUCTION
The global HIV-1 pandemic is driven by geographical, gender, and socio-economic 
disparities (1). In North America and Europe, HIV burden is concentrated among 
marginalized and stigmatized populations, including sexual minorities and communities of 
color. In the United States (U.S.), men who have sex with men (MSM) are 
disproportionately affected, comprising 62% of HIV-1 diagnoses each year (2), and African 
Americans account for 44% of prevalent infections despite making up only 14% of the 
population (3). Transgender women (TGW; i.e., individuals assigned male at birth but who 
identify as female) are estimated to have an HIV prevalence of 27.7% (4), even higher than 
the 25% prevalence estimated for MSM (5). Of concern, African American TGW had even 
higher prevalence, averaging 56.3% (4). In parallel, cross-sectional HIV testing in Miami, 
San Francisco, and Los Angeles found an HIV prevalence rate of 12% among TGW with no 
previous test result indicating a high frequency of undiagnosed infection (4, 6).
Analysis of viral genetic sequences provides a route to uncovering transmission dynamics 
(7). HIV is particularly amenable to phylogenetic analysis, because of its rapid rate of 
evolution, making it possible to identify genetic networks of densely connected 
subpopulations (i.e., molecular transmission clusters) (8). These transmission clusters are 
presumed to comprise people at increased risk of HIV transmission or evidence of recent 
transmission events; however, densely sampled/sequenced sub-populations can also form 
clusters, even in the absence of increased transmission rates (9, 10). These clustering 
approaches have the capability to reveal patterns hidden from traditional epidemiological 
approaches [e.g., obscured transmission risk behaviors, like self-reported heterosexual males 
whose viruses cluster only with those from MSM (11, 12)].
California shoulders the second largest number of people living with HIV-1 in the U.S. as of 
2014 (with 119,589 cases), following New York State (130,753 cases) (3). Within 
California, Los Angeles County (LAC) had the greatest number of HIV diagnoses in 2015 
and has the largest burden of persons living with HIV infection in the State: 60,000. The 
LAC HIV epidemic is dominated by MSM, who account for 83% of recent diagnoses (2), 
Since 2006, HIV-1 genetic sequences, generated for routine antiretroviral resistance 
genotyping, have been reported to the LAC Department of Public Health.
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Here, we reconstructed the HIV-1 genetic transmission network from the LAC surveillance 
database, with a focus on transmission risk among TGW. We found that despite documented 
low rates of diagnosis (4), TGW clustered at higher rates than other risk groups. 
Furthermore, TGW were more likely than expected to link to each other and to cisgender 
males with a sexual transmission risk, rather than to MSM. We discuss how these results 
reveal a novel molecular epidemiological strategy that could be used to improve HIV-1 
diagnosis rates in TGW and potentially reduce new HIV infections.
METHODS
Data sources
Since 2006, HIV-1 protease and reverse transcriptase (pol) genetic sequences generated 
during routine antiretroviral drug resistance testing have been reported to the LAC 
Department of Public Health. As of 2016, LAC HIV surveillance had received HIV-1 
genetic sequences from 22,398 individuals residing or receiving care in LAC. Of 60,000 
people estimated to be living with HIV, 49,976 had been diagnosed by 2015, thus 44.8% of 
diagnosed persons had a sequence available. We used the first genotype available for each 
individual. Information on treatment has been collected since 2006, and 69% of new cases 
since 2006 were treatment naïve at the time of their first genotype. Deduplication of cases is 
performed within the LAC database via a comprehensive procedure based on name, date of 
birth, address, and social security number.
For each case reported to the local HIV surveillance system, additional clinical and 
demographic data are available in the enhanced HIV/AIDS Reporting System (eHARS). We 
define TGW as people who were assigned male sex at birth but identify as women. In the 
LAC HIV surveillance database, transgender information was initially collected in a 
combined sex/gender field (male, female, male-to-female transgender, and female-to-male 
transgender) starting in the late 1990s. From 2009 onwards, a two-step method was 
implemented in the HIV/AIDS adult case-report form to identify transgender individuals, 
recording sex at birth alongside current gender identity. There are a variety of data sources 
for sex and gender information which may include provider reports (as abstracted from 
medical charts, physician’s notes, and self-administered patient intake sheets), laboratory 
test reports, the Ryan White Program client registry, and public health investigation by 
surveillance and partner services staff. Other data available in eHARS include race/ethnicity 
(American Indian/Alaska Native, Asian/Pacific Islander, Black/African-American, Latino, 
White or multi-racial), transmission risk factor (MSM, people who inject drugs [PWID], 
MSM/PWID, heterosexual, perinatal, other, unknown), age at diagnosis, date of diagnosis, 
CD4 count at diagnosis, and date of last negative test. Age at diagnosis was treated as a 
categorical variable (0–12, 13–19, 20–29, 30–39, 40–49, 50–59, 60+) and date of diagnosis 
was analyzed as a continuous variable using month and year only. Where date of last 
negative test was available and less than 6 months before a positive HIV test, we classified 
individuals as “early” diagnoses. As a proxy for time since infection for other cases, we used 
CD4 count: >500, 200–500, <200 cells per μL.
A TGW who reports sex with cis-men may be classified as heterosexual (corresponding to 
their gender identity) or MSM (corresponding to their birth sex but disregarding their gender 
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identity). Therefore, for TGW, we collapsed transmission risk factor into two categories: 
TGW who reported injection drug use (TGW-PWID) and the remaining TGW who did not 
report injecting drugs and were likely to have been infected through sex. We classified this 
group as having a sexual risk factor (TGW-Sex). To permit meaningful comparison with 
cisgender males and females (individuals who identify with the sex they were assigned at 
birth), we categorized all cisgender individuals who reported injection drug use as PWID 
and those who reported perinatal exposure or other transmission risk factor as “other”. 
Individuals who reported heterosexual risk or no risk were classified as having sexual 
transmission risk. As such, the final risk categories differed from those assigned by HIV 
surveillance (see below).
The study was approved by both the University of California, San Diego and LAC 
Department of Public Health Institutional Review Boards.
Phylogenetic analyses
A molecular transmission network was constructed from genetic sequences using HIV-
TRACE (13). In brief, HIV pol sequences were aligned to an HXB2 reference sequence and 
pairwise genetic distances were calculated under the Tamura-Nei 93 model. We did not 
remove codons associated with drug resistance as their removal has been demonstrated not 
to affect clustering using HIV-TRACE in similar datasets (14, 15). Each individual in the 
network is represented by a node, and nodes were linked to each other if their pairwise 
genetic distance was ≤0.015 substitutions/site. This threshold is in line with the expected 
divergence between sequences within an individual (16) and is in accordance with the 
genetic distance seen between named HIV risk partners (15). We further tested the 
sensitivity of our epidemiological inference at distance thresholds of ≤0.01 and ≤0.02 
substitutions/site. Nodes linked to at least one other node are considered “clustered” in the 
transmission network. Ninety-seven percent of sequences were subtype B, but HIV-TRACE 
can create a single network regardless of subtype.
Statistical analyses
Clustered sequences are closely related genetically, indicating that they are likely to be part 
of the same transmission chain, and high rates of clustering within a population suggest 
increased rates of transmission. Therefore, we assessed the correlates of clustering using 
multivariate and univariate logistic regression. Date of HIV diagnosis, transmission risk 
group, age at diagnosis, race/ethnicity, CD4 count/early infection, and country of birth (U.S./
U.S.-territories vs. foreign-born) were included as covariates in the multivariate regression 
models. Individuals for whom information was missing for one or more of these categories 
were categorized as “unknown”. For the purpose of the logistic regression, gender and 
transmission risk category were combined into a single variable. As such, our final 
transmission risk groups were: sexual risk cisgender females (F-Sex), cisgender female 
PWID (F-PWID), TGW-PWID, TGW-Sex, sexual risk cisgender males (M-Sex), MSM, 
MSM/PWID, cisgender male PWID (M-PWID), transgender men, and other 
(Supplementary Figure 1, Appendix p5). The “other” category comprised perinatal cases, 
blood product recipients and individuals for whom transmission risk could not be 
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ascertained. Using the same method and covariates, we then assessed the correlates of non-
TGW cases clustering with TGW in the transmission network.
Assortativity is a network metric which describes, for a given characteristic (e.g., 
transmission risk factor) the tendency for nodes to link to other nodes with the same trait 
(i.e., do PWIDs link to PWIDs?) (17). Assortativity varies between -1 (completely 
disassortative) and 1 (completely assortative) and was calculated using the function available 
in the R igraph package v1.2.1 (18). F-Sex and M-Sex, and F-PWID and M-PWID, were 
combined into cisgender males and females with sexual risk and cisgender males and 
females who report injecting drugs, respectively, for this analysis, as we would expect them 
to mix with each other.
In parallel, we counted links in the network between each pair of transmission risk groups to 
estimate mixing patterns between TGW and other groups (17). In order to adjust for degree 
(i.e., the total number of links connecting a given node), the number of links for each 
individual was divided by that individual’s degree. This correction was performed because 
some individuals have far more links than others but we do not wish to over count those 
individuals’ contribution to mixing between transmission risk groups. Assortativity is 
influenced by the ratio of node labels (PWID, MSM etc.). To assess the statistical 
significance of observed patterns of mixing and assortativity given the relative representation 
of each transmission risk group in these clusters, we generated expected distributions for 
parameters by randomly permuting transmission risk group labels on the static network 
1,000 times in R v3.4.1.
RESULTS
In the LAC transmission network, 8,133 of 22,398 (36.3%) unique individuals were 
clustered at 0.015 substitutions/site. The network was composed of 1,722 clusters 
comprising between 2 and 116 nodes (Figure 1, Supplementary Figures 2 & 3, Appendix 
p6). The majority of the sequences in the surveillance database (14,932/22,398; 67%) were 
from MSM, and this proportion was even greater among clustered sequences (5993/8133; 
73.7%). The LAC dataset contained sequences and demographic data from 412 TGW, 
including 67 TGW-PWID. The mean age of TGW at diagnosis was 29 years and their 
average current age was 50. TGW were less likely to be White than other cases in the dataset 
(Fisher’s exact test; p<0.001; Figure 2). The number of sequences collected and the 
proportion of sequences clustering each year have increased overall, and for TGW-Sex 
specifically, but for not TGW-PWID, as diagnoses among PWID have decreased over time 
in LAC (2) (Supplementary Figure 4, Appendix p8).
We sought to determine which demographic/risk characteristics were associated with 
clustering in order to identify subpopulations with higher rates of transmission. TGW-Sex 
clustered at the highest frequency in the network (42.6%, compared with 40.1% for MSM) 
(Figure 3) and had the highest odds of clustering in the univariate analyses (p<0.001; 
Supplementary Table 1). In the multivariate analysis, the adjusted odds ratio (AOR) for 
clustering was even higher for TGW-PWID than for TGW-Sex and MSM (Figure 3). 
However, the AOR for clustering of TGW-PWID were affected by the date of the HIV 
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diagnosis, with 90% of TGW-PWID diagnoses having taken place before 2007 
(Supplementary Figure 4, Appendix p8), and consequently their odds of clustering were 
lower than TGW-Sex in the univariate analysis (Supplementary Table 1, Appendix p1). 
Individuals diagnosed with a higher CD4 count, likely to have been diagnosed closer to the 
time of infection, were more likely to cluster but the effect was modest. Individuals with a 
documented negative HIV-test within 6 months prior to diagnosis, classified as “early”, were 
more likely to cluster in the univariate analysis, but this effect was not significant in the 
multivariate model (Supplementary Table 1, Appendix p1, Figure 3). An age trend was 
apparent, with younger individuals significantly more likely to cluster and older individuals 
significantly less likely to cluster (Figure 3). Individuals of Latino ethnicity were the largest 
racial/ethnic group (44.2% of population) and the group most likely to cluster. Individuals 
born outside the U.S. were less likely to cluster than those born in the U.S./US-Territories. 
Variables associated with clustering were consistent across genetic distance thresholds 
(Supplementary Table 2, Appendix p2).
We estimated assortativity, the tendency of nodes sharing attributes to link together, by 
transmission risk group, across the network. The 167 TGW were distributed across 126 
clusters, with 21 clusters containing >1 TGW. Whereas only 503/21,986 (2.3%) of non-
TGW individuals linked to at least one TGW in the network, 106/503 (21.1%) of those 
linked to a second TGW (Figure 1). Therefore, individuals linked to one TGW were 9.2 
times more likely to link to two TGW than other individuals in the surveillance database. 
MSM, MSM/PWID, cisgenders with a sexual risk, TGW-Sex and TGW-PWID were all 
significantly assortative in the network (Figure 4). MSM were most likely to link to each 
other (Assortativity coefficient = 0.17; p<0.001). The assortativity coefficient for TGW with 
sexual transmission risk was 0.06 (p<0.001; i.e., an assortativity coefficient this extreme was 
not observed in any of the 1000 network permutations); however, absolute assortativity of 
TGW was low relative to cisgenders with a sexual risk and MSM, because the total number 
of TGW in the network is small. In contrast, cisgender PWID did not link assortatively, 
indicating that they were dispersed among other risk groups in the network. At genetic 
distance thresholds of ≤0.01 and ≤0.02 substitutions per site, MSM, cisgenders with a sexual 
risk and TGW-Sex remained highly significantly assortative (Supplementary Figure 5, 
Appendix p9).
We characterized the subpopulations clustering with TGW by constructing a linear 
regression model distinguishing between non-TGW clustering with TGW and those that did 
not. M-Sex, MSM/PWID, and M-PWID were all more likely than MSM to be clustered with 
TGW; and foreign-born individuals were less likely to cluster with TGW than U.S. born 
individuals (Table 1). There were no significant differences by age or race/ethnicity.
Finally, we explored the connectivity between each pair of transmission risk groups, 
adjusting for node degree, to determine who TGW linked to. The network reconstruction 
method creates a network in which far more links are present than in the true transmission 
network. Because the vast majority of the nodes in the network represent MSM, we expect 
high linkage to MSM for all transmission risk groups, and that is indeed what we observed 
(Supplementary Table 4). Nonetheless, we also observed trends towards TGW-Sex and 
TGW-PWID linking to each other as well as with M-Sex. To assess the statistical 
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significance of this observation, we estimated the expected proportion of links between 
TGW-Sex and TGW-PWID and each of the other risk groups using the randomly permuted 
networks (Table 2). For both TGW-Sex and TGW-PWID, the proportion of links to TGW-
Sex and TGW-PWID was higher than expected, whereas the proportion of links to MSM 
was 25–30% lower than expected. For TGW-Sex, the proportion of links with M-Sex was 
higher than expected. Nonetheless the majority of TGW links (75%) were with MSM. 
Identical mixing patterns were seen across genetic distance thresholds (See Supplementary 
Tables 3, 4 and 5, Appendix p3, which include an extended version of Table 2, displaying 
mixing between every pair of transmission risk groups).
DISCUSSION
We found that TGW had the highest odds of clustering in the LAC network, indicating that 
their risk of being in a molecular transmission cluster exceeds that of even MSM. Our 
findings also reveal that TGW occupy a distinct position in the LAC transmission network. 
TGW were significantly more likely to be the genetically-linked partners of cisgender males 
not reporting injection drug use or MSM contact (M-Sex) than expected. Furthermore, TGW 
tended to cluster assortatively with other TGW in the network (i.e., having one TGW in a 
cluster increased the odds of finding another TGW in that same cluster).
The patterns of clustering among TGW observed here suggest a potentially powerful 
strategy for using the molecular transmission network to improve public health outcomes. 
Assortativity among TGW indicates that non-TGW who are genetically linked to a TGW are 
nine times more likely to be clustered with a second TGW. Based on this finding, we 
propose that non-TGW with a genetic link to a TGW may be more likely to identify 
additional HIV-infected or at-risk TGW via partner services, than non-TGW who are not 
genetically linked to TGW. At present, in LAC and in much of the U.S., partner elicitation 
services are not universally offered. Further, typically less than half of interviews result in 
the identification of a partner (19). Molecular epidemiology could be used to prioritize these 
genetically linked non-TGW cases for partner elicitation interviews by public health 
investigators, with the expectation of identifying more HIV-infected, undiagnosed TGW, 
high-risk HIV-uninfected TGW, or HIV-infected TGW who are not in care. This targeted 
approach could lead to improved HIV diagnosis, linkage to HIV care, and pre-exposure 
prophylaxis (PrEP) access among TGW.
Clearly, the named sexual partners of TGW should also continue to be considered a high 
priority group for HIV research and interventions. In interviews, 20% of the male partners of 
TGW have reported being HIV-positive (20, 21). Although TGW think of themselves as a 
distinct community, their non-TGW partners may not, which makes them more difficult to 
identify (20). Molecular epidemiology represents a tool to identify this high-risk population. 
Importantly, if validated, this type of network-targeted approach would be applicable to any 
group that clusters assortatively in a molecular transmission network. Nonetheless, we 
acknowledge that there is a difference between the individuals named during a partner 
services interview and those individuals with a genetic link (15).
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Genetic clustering methods have been rightly criticized for potential bias towards identifying 
subpopulations with higher sampling rates rather than higher transmission rates (22–24). 
Consistently high frequencies of clustering among MSM (14, 25, 26) and individuals 
diagnosed with acute/early stage infection (23, 27) may reflect elevated diagnosis rates 
rather than exceptional transmission rates; thus, clustering analyses could potentially divert 
public health focus from where it is most needed (22). That being said, high clustering has 
been consistent with shorter transmission intervals in time-resolved analyses (8), and the 
algorithm used here has demonstrated ability to detect subpopulations with higher 
transmission rates in simulations (22). Strikingly, in our analysis, the highest clustering rates 
were seen among TGW, a group documented to have low diagnosis rates (4, 6, 28), 
suggesting that in this instance, a genetic clustering approach works well as a tool to identify 
a hidden high risk population in the absence of increased sampling rates. However, the 
proportion of people recently diagnosed with HIV-1 in LAC who have a reported pol 
sequence is only between 40–50%, suggesting the potential for sampling bias. Further, TGW 
are more likely to engage in care after HIV diagnosis (29), increasing the likelihood of 
having an HIV sequence in the surveillance database. To address this potential bias, we used 
CD4 count at diagnosis as a proxy for time since infection in our multivariate regression. 
Although a higher CD4 count (suggesting a shorter time between infection and diagnosis) 
was indeed associated with clustering, the effect was weak and our main finding was robust 
including this covariate. Furthermore, all genetic network analyses, such as this one, are 
limited because they geographically constricted and affected by sampling, and we cannot 
account for migration or transmission events occurring outside of LAC. Nonetheless, as we 
found that individuals from outside the U.S. were less likely to cluster than those from 
within the U.S., this migration should not bias our results.
Importantly, a limitation of our clustering analysis is that HIV-TRACE does not infer 
directionality, and we cannot distinguish between transmitters and recipients in our clusters. 
However, our inference is not unduly influenced by this limitation, because identifying 
genetically linked partners is sufficient for deciding whether to prioritize individuals for 
public health interventions. We find that TGW are more likely to be involved in HIV 
transmission events, but we cannot state whether they more frequently the transmitter or 
recipient. This finding highlights the importance of allocating public health and other 
services towards the HIV-infected and at-risk transgender community.
Our finding that TGW link preferentially to M-Sex (who will be composed mainly of male 
heterosexuals) is particularly meaningful given that MSM have far higher HIV prevalence 
than male heterosexuals and are expected to be the source of the majority of infections. This 
finding is in agreement with interviews of TGW (4) and their partners (20). In a study of 
male partners of TGW in San Francisco, half the TGW described themselves as straight, and 
only 10% identified as gay (20). Although the genetic transmission network alone does not 
conclusively reveal source of infection for TGW (sex with M-Sex, sex with MSM, or shared 
needles), traits-based phylogenetic analysis on these clusters may further elucidate 
transmission risk for TGW. Nonetheless, reliance on self-reporting of transmission risk can 
be influenced by MSM who do not disclose their risk factors (11, 12). Reliable estimates of 
TGW and diagnosis rates in U.S. populations are unfortunately lacking, but would be helpful 
for assessing the impact of public health services provided to TGW and their partners.
Ragonnet-Cronin et al. Page 8
Lancet HIV. Author manuscript; available in PMC 2019 December 02.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
In conclusion, we report that TGW in LAC were more likely to cluster in a molecular 
transmission network than other risk groups, suggesting high transmission rates—despite 
low representation of TGW in the database. TGW were genetically linked to M-Sex more 
than expected and to MSM less than expected. TGW tended to be part of the same clusters, 
indicating linkage either directly or through shared partners. This assortativity highlights the 
potential to use molecular epidemiology to both identify transmission clusters likely to 
include undiagnosed or undisclosed HIV-infected TGW and improve public health 
prevention and treatment activities towards TGW.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Evidence before this study
We searched Google scholar for the terms “HIV” “genetic”, “transmission” “networks” 
on 4th June 2018, then added the term “transgender” to the search, with no date limits. 
HIV is spread through contacts within a sexual network. The virus accumulates genetic 
mutations within the same timeframe as transmission events. The transmission history of 
the virus is a subset of the network that can be reconstructed from HIV genetic sequences 
(although some transmission events may be missed for various reasons). The structure of 
the reconstructed transmission network can be informative in terms of risk factors 
associated with transmission and to inform interventions. Furthermore, several studies 
have demonstrated that it is possible to gain insights into transmission of HIV among 
groups difficult to investigate using traditional epidemiological tools such as contact 
tracing. We found no molecular epidemiological analyses specific to transgender women, 
despite them being one of the groups with the highest prevalence of HIV in the United 
States.
Added value of this study
We reconstructed the HIV transmission network using all HIV sequences available from 
Los Angeles County. We identified transgender women within these networks and looked 
at how they were connected to other risk groups in the network. We found that 
transgender women were more connected to each other and to heterosexual men, and less 
connected to men who have sex with men, than expected.
Implications of all the available evidence
The way in which people are connected through the genetic transmission network 
provides information on transmission patterns within the population. Transmission 
clusters comprising at least one transgender woman are attractive targets for interventions 
aimed at finding additional undiagnosed and at-risk transgender women, because 
individuals within that cluster are more likely to have other transgender women among 
their sexual/ social contact networks. This study highlights the potential for molecular 
epidemiology to guide interventions towards subpopulations with high HIV prevalence 
but low diagnosis rates.
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Figure 1: 
Molecular transmission clusters in Los Angeles County with at least one transgender woman 
(TGW). Node shape denotes gender and color denotes transmission risk factor. Edges 
represent genetic distance of ≤0.015 substitutions/site. Sex, sexual risk; PWID, people who 
inject drugs; TGW, transgender women; MSM, men who have sex with men.
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Figure 2: 
Race/ethnicity of transgender women (TGW) and other individuals with sequence data 
available in the Los Angeles County dataset. There were 412 individuals in the TGW group 
compared to 21,986 non-TGW. AI/NA, American Indian/Native Alaskan; PI, Pacific 
Islander; AA, African American. TGW were less likely to be white than other cases in the 
dataset (Fisher’s test, p<0.001).
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Figure 3: 
Demographic breakdown of the persons reported with HIV-1 sequence data in LAC with 
adjusted odds ratio (AOR) for clustering. The “total” column indicates the number of 
individuals in the LAC surveillance population in that category and the “clustered” column 
indicates the number and percentage of individuals in that category who were clustered. The 
AOR for diagnosis date indicates that individuals diagnosed in each year were 1.18 times 
more likely to be clustered than individuals sampled in the previous year. Individuals 
classified as “Early” are those who tested negative for HIV within 6 months before 
diagnosis. F-PWID, cisgender female person who injects drugs; F-Sex, female with sexual 
risk; M-PWID, cisgender male person who injects drugs; M-Sex, cisgender male with sexual 
risk; MSM men who have sex with men; MSM/PWID men who have sex with men and 
inject drugs; TGM, transgender men; TGW-PWID, transgender women who inject drugs; 
TGW-Sex, transgender women with sexual risk. * indicates p<0.05, ** p<0.01, and *** 
p<0.001.
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Figure 4: 
Assortativity broken down by self-reported risk group. The null distribution of expected 
assortativity is shown in grey and the observed assortativity for each risk group is displayed 
in a different color. MSM, men who have sex with men; Sex, sexual risk; TGW-Sex, 
transgender women with sexual risk; PWID, people who inject drugs; TGW-PWID, 
transgender women who inject drugs. Significant assortativity is denoted by **p<0.01, 
***p<0.001.
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Table 1:
Correlates of clustering with transgender women
AOR 95% CI
Diagnosis year 1.03*** 1.01 – 1.04
RISK
MSM -
Cisgender male Sex 1.74*** 1.45 – 2.07
MSM/PWID 1.39* 1.03 – 1.85
Cisgender male PWID 1.79* 1.07 – 2.86
BIRTH COUNTRY
U.S./ U.S. Territories -
Foreign-born 0.81* 0.67 – 0.97
Only variables with significant association in the multivariate regression model are shown. MSM, men who have sex with men; Sex, sexual risk; 
PWID, people who inject drugs; AOR, adjusted odds ratio; CI, confidence interval;
*p<0.05,
***p<0.001.
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Table 2:
Ratio of the observed proportion of pairwise links compared to the mean of the simulated proportion of 
pairwise links (and 95% confidence intervals). Ratios above 1 indicate an overrepresentation of those 
relationships in the true network compared to random expectation and ratios below 1 indicate an 
underrepresentation of those relationships.
F-Sex F-PWID TGW-PWID TGW-Sex M-Sex MSM MSM/PWID M-PWID
TGW-Sex 1.09 0.73 6.55*** 4.65*** 1.53** 0.75** 1.68** 1.82*
(0.81–1.62) (0.25-Inf) (1.5-Inf) (2.08-Inf) (1.21–2.01) (0.71–0.8) (1.11–2.6) (1.05-Inf)
TGW-PWID 0.72 0 11.99*** 6.9*** 1.38 0.69** 2.43* 2.65
(0.37–4.4) (0-NaN) (2.2-Inf) (1.97-Inf) (0.78–5.2) (0.59–0.85) (1.07–9.6) (0.48-Inf)
F, cisgender female; PWID, people who inject drugs; TGW, transgender women; Sex, sexual risk; M, cisgender male; MSM, men who have sex 
with men.
*p<0.05,
**p<0.01,
***p<0.001.
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